Innovative Health Diagnostics and AIMA Laboratories Collaborate to Develop New, Revolutionary At-Home Test to Detect Endometriosis

Both laboratories join forces to expand access to an important and reliable endometriosis blood test that can be self-administered anytime, anywhere

IRVINE, Calif.–(BUSINESS WIRE)–Innovative Health Diagnostics (IHD), a CLIA- and FDA-certified lab that empowers every person by providing access to accurate, clinical testing, announced today a new partnership with AIMA Laboratories (AIMA), a preclinical FemTech company dedicated to developing new products that fill current gaps in gynecological health, to develop and deliver a new and reliable at-home blood test to detect endometriosis.

Endometriosis is a disease where tissue similar to the lining of the uterus grows outside the uterus, causing pain and/or infertility. For the roughly 10% of reproductive age women and girls globally who have endometriosis – approximately 190 million – there is a significant gap between when symptoms first appear and when they are diagnosed, which can typically take around 5 to 12 years.

Read the original article.

Metadata
Share this article!
We Need Your Help graphic

Make your voice heard!

Sign our petition to urge the government to invest $100M in the Femtech Challenge for the 2025 Budget. Let’s reinforce Canada’s leadership in women’s health and advance gender equality.

Our website uses cookies to ensure you get the best experience. Learn More